Zimmer Biomet Holdings, Inc. (ZBH) Stock Rating

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants along with supplies and surgical equipment for orthopedic surgery. Following its acquisitions of Centerpulse (2003) and Biomet (2015), it holds the leading reconstructive market share in the US, Europe, and Japan. About two-thirds of revenue comes from large joints and about a fourth from extremities, trauma, sports medicine, and related products. It spun off its dental and spine businesses in 2022.

Rating as of 2026-07-03. Live price updates in real time.